The 1-year mortality was 5% and 11% higher in women in the early and late periods, respectively, although it did not reach statistical significance in the early period (HR 1.05, 95% CI 0.97 to 1.14 vs HR 1.11, 95% CI 1.00 to 1.24).
← all excerpts
Time trends in STEMI--improved treatment and outcome but still a gender gap: a prospective observational cohort study from the SWEDEHEART register.
1
—
—